Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00642876 · ClinicalTrials.gov registry record · NA
PRESTIGE® Cervical Disc Study
A NA study, sponsored by Medtronic Spinal and Biologics.
- Completed
- Registry status
- NA
- Development phase
- 541
- Enrollment target
NCT00642876: Completed NA study, sponsored by Medtronic Spinal and Biologics.
NCT00642876 is a NA study that has completed, run by Medtronic Spinal and Biologics. The registered enrollment target is 541 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00642876, a NA study, has completed, sponsored by Medtronic Spinal and Biologics.
- COMPLETED
- Registry status
- NA
- Development phase
- 541 participants
- Enrollment target
Study Summary
The purpose of this clinical investigation is to evaluate the safety and effectiveness of the ACD in the single level surgical treatment of patients with symptomatic cervical degenerative disc disease. The primary follow-up information obtained from this clinical investigation are used to support a PMA application for the ACD.
Interventions
- DEVICE Allograft Fusion and ATLANTIS™ Cervical Plate System
- DEVICE PRESTIGE® Cervical Disc
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 541 participants |
| Start Date | 2002-10 |
| Est. Completion | 2013-05 |
| Phase | NA |
What the finished NCT00642876 record still lists
NCT00642876 is an interventional study that assigns participants to a tested intervention. The registered 541 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% lower).
The record links to 0 conditions, and to 2 interventions - of which Allograft Fusion and ATLANTIS™ Cervical Plate System is the first listed.
NCT00642876 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00642876 about?
NCT00642876 is a clinical study titled "PRESTIGE® Cervical Disc Study". The purpose of this clinical investigation is to evaluate the safety and effectiveness of the ACD in the single level surgical treatment of patients with symptomatic cervical degenerative disc disease. The primary follow-up information obtained from this clinical investigation are used to support a ...
What is the current status of trial NCT00642876?
This trial is currently completed. It is a NA study. The enrollment target is 541 participants. The study started on 2002-10. Estimated completion is 2013-05.
What interventions are being tested in trial NCT00642876?
The interventions under investigation include: Allograft Fusion and ATLANTIS™ Cervical Plate System (DEVICE), PRESTIGE® Cervical Disc (DEVICE).
Who is sponsoring clinical trial NCT00642876?
This trial is sponsored by Medtronic Spinal and Biologics, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00642876's enrollment target sits among peer trials
541 187th of 2000 higher than 1,814 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04929223 · 542 participants · Phase 1
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
- NCT05584670 · 542 participants · Phase 1
A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors
- NCT04557462 · 540 participants · Phase 3
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- NCT04956640 · 540 participants · Phase 1
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia